Skip to content

Myriad Genetics MYGN Mental Health — Revenue

Other product segments

Cancer Care Continuum
$120.2M
Hereditary Cancer
$96.8M+2.5%
Prenatal
$44.9M0.0%
Prenatal Health
$41.9M

Similar metrics at other companies

Universal Health Services logo
UHSBehavioral Health Services — Revenue
$1.88B+8.2%
OraSure Technologies logo
OSURProducts and services — Net revenues
$26.38M-9.0%
Omada Health, Inc. Common Stock logo
OMDAServices — Revenue
$69.59M+40.6%
GeneDx Holdings logo
WGSDiagnostic Test — Total Revenue
$101.3M+18.1%
American Public Education logo
APEIHealth+ — Revenue
$85.36M+11.0%
Concentra Group Holdings Parent logo
CONConsumer health — Revenue
$7.83M-9.1%

Other financials

Income statement

See full
Revenue$200.4M+2.3%
Gross profit$137.6M+2.5%
Operating income-$30.7M-5.9%
Net income-$34.1M-34,000%
EPS (diluted)-$0.36

Balance sheet

See full
Cash & equivalents$126.0M+24.8%
Total debt$211.5M+34.2%
Total equity$337.4M-52.1%
Total assets$673.7M-33.0%

Cash flow

See full
Operating cash flow-$15.7M+3.7%
CapEx$18.8M+181%
Free cash flow-$19.7M+65.1%

Valuation

See full
Market cap$512.85M+13.1%
Enterprise value$598.35M+17.3%
P/S0.6×+0.1×

Profitability

See full
Gross margin70%0.0pp
Operating margin-46.9%-88.3pp
Net margin-48.2%-72.9pp
FCF margin-17%

Returns & leverage

See full
Return on equity-76.7%-98.4pp
Debt / equity0.6×+0.4×
Current ratio2.4×+0.5×

Where this comes from

Reported directly by Myriad Genetics in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Myriad Genetics's mental health — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Myriad Genetics's mental health — revenue?
Myriad Genetics (MYGN) reported mental health — revenue of $38.3M in Q1 2026.
How has Myriad Genetics's mental health — revenue changed year-over-year?
Myriad Genetics's mental health — revenue increased by 23.5% year-over-year, from $31M to $38.3M.
What does mental health — revenue mean?
This metric represents the total gross revenue generated from the sale of diagnostic testing services and products specifically focused on mental health and psychotropic drug response optimization. It reflects the commercial performance and market adoption of the company's psychiatric diagnostic portfolio. Monitoring this revenue stream provides insight into the company's diversification strategy and its ability to capture value within the behavioral health diagnostics market.